Rare diseases
Investigational molecules
Locations
Via Alvaro Del Portillo 200, 00128 Rome, Italy
Universita' Campus Bio-medico Di Roma in Rome, Italy specialises in clinical trials of conditions such as Non-small cell lung cancer, Sjogren's syndrome, Metabolic dysfunction-associated steatohepatitis, Migraine, and other specialisations. This site conducts important research.
At Universita' Campus Bio-medico Di Roma in Rome, the clinical trial activity is centered on cardiovascular diseases, with a focused effort on understanding and preventing myocardial injury in people hospitalized with pneumonia. The studies are designed to assess whether a potential add-on therapy can help protect the heart while patients are being treated for infection.
This research area reflects a close intersection between cardiology and infectious disease care, with the goal of improving outcomes for patients at risk of cardiac damage during respiratory illness.
The site is also conducting trials focused specifically on preventing myocardial injury in the setting of pneumonia. These studies aim to determine whether an additional treatment can offer heart protection for hospitalized patients and support safer recovery during acute illness.
With 51 investigators involved across 5 clinical trials, the research program shows a strong collaborative effort within the Department of Cardiovascular Diseases to address a clinically important complication of infection.
Clinical trials currently enrolling participants at this site.
Phase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer
ItalyA study to evaluate the effects of zenagamtide on weight and pain in patients with overweight or obesity and knee osteoarthritis
ItalyA study to evaluate the efficacy and safety of zenagamtide in people with overweight or obesity and knee osteoarthritis
ItalyA Phase III Study of Survodutide in Adults with Compensated NASH Cirrhosis to Assess Liver Outcomes and Safety
ItalyA Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis
ItalyStudy of BNT327 and a drug combination for patients with untreated metastatic or locally recurrent triple-negative breast cancer
ItalyA study to evaluate the safety of dazodalibep in patients with Sjögren's Syndrome over a long period of time
ItalyStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
ItalyStudy of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease
ItalyStudy on the Safety and Effectiveness of BNT327 with Chemotherapy for Patients with Non-Small Cell Lung Cancer
ItalyItalyStudy on Eltrekibart and Mirikizumab for Adults with Moderate to Severe Ulcerative Colitis
ItalyMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
